ReviewJournal of hematology & oncology2010

First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib.

Guoqing Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.